Doris Benbrook to OX40 Ligand
This is a "connection" page, showing publications Doris Benbrook has written about OX40 Ligand.
Connection Strength
0.039
-
Anti-CD73 and anti-OX40 immunotherapy coupled with a novel biocompatible enzyme prodrug system for the treatment of recurrent, metastatic ovarian cancer. Cancer Lett. 2018 07 01; 425:174-182.
Score: 0.039